Does PASIREOTIDE DIASPARTATE Cause Neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm progression have been filed in association with PASIREOTIDE DIASPARTATE. This represents 1.8% of all adverse event reports for PASIREOTIDE DIASPARTATE.
5
Reports of Neoplasm progression with PASIREOTIDE DIASPARTATE
1.8%
of all PASIREOTIDE DIASPARTATE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm progression From PASIREOTIDE DIASPARTATE?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PASIREOTIDE DIASPARTATE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PASIREOTIDE DIASPARTATE Cause?
Nausea (66)
Off label use (42)
Fatigue (40)
Diarrhoea (38)
Blood glucose increased (36)
Diabetes mellitus (35)
Dizziness (34)
Vomiting (34)
Headache (33)
Hyperglycaemia (20)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which PASIREOTIDE DIASPARTATE Alternatives Have Lower Neoplasm progression Risk?
PASIREOTIDE DIASPARTATE vs PATIROMER
PASIREOTIDE DIASPARTATE vs PATISIRAN
PASIREOTIDE DIASPARTATE vs PAXIL
PASIREOTIDE DIASPARTATE vs PAZOPANIB
PASIREOTIDE DIASPARTATE vs PEANUT